Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep;13(9):1538-1541.
doi: 10.4103/1673-5374.237111.

Utilizing zebrafish and okadaic acid to study Alzheimer's disease

Daniel Koehler  1 , Frederick E Williams  1
Affiliations
Review

Utilizing zebrafish and okadaic acid to study Alzheimer's disease

Daniel Koehler et al. Neural Regen Res. 2018 Sep.

Abstract

Despite the many years of extensive research using rodent models to study Alzheimer's disease (AD), no cure or disease halting drug exists. An increasing number of people are suffering from the disease and a therapeutic intervention is needed. Therefore, it is necessary to have complementary models to aid in the drug discovery. The zebrafish animal model is emerging as a valuable model for the investigation of AD and neurodegenerative drug discovery. The main genes involved in human AD have homologous counterparts in zebrafish and have conserved function. The basic brain structure of the zebrafish is also conserved when compared to the mammalian brain. Recently an AD model was established by administering okadaic acid to zebrafish. It was used to test the efficacy of a novel drug, lanthionine ketimine-5-ethyl ester, and to elucidate its mechanism of action. This demonstrated the ability of the okadaic acid-induced AD zebrafish model to be implemented in the drug discovery process for therapeutics against AD.

Keywords: Alzheimer's disease; Zebrafish; lanthionine ketimine-5-ethyl ester; learning and memory; okadaic acid; protein phosphatase 2A.

PubMed Disclaimer

Conflict of interest statement

None declared

References

    1. Alzheimer’s Association. 2018 Alzheimer’s disease facts and figures. Alzheimers Dement. 2018;14:367–429.
    1. Collier AD, Echevarria DJ. The utility of the zebrafish model in conditioned place preference to assess the rewarding effects of drugs. Behav Pharmacol. 2013;24:375–383. - PubMed
    1. Eddins D, Cerutti D, Williams P, Linney E, Levin ED. Zebrafish provide a sensitive model of persisting neurobehavioral effects of developmental chlorpyrifos exposure: comparison with nicotine and pilocarpine effects and relationship to dopamine deficits. Neurotoxicol Teratol. 2010;32:99–108. - PMC - PubMed
    1. Goedert M, Jakes R, Qi Z, Wang JH, Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates tau protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem. 1995;65:2804–2807. - PubMed
    1. Hamley IW. The amyloid beta peptide: a chemist’s perspective. Role in Alzheimer’s and fibrillization. Chem Rev. 2012;112:5147–5192. - PubMed

LinkOut - more resources